In situ hybridization to detect DNA amplification in extracellular vesicles.
EV embedding
EV in situ hybridization
EVs
FISH
extracellular vesicles (EVs)
sarcoma
tissue
Journal
Journal of extracellular vesicles
ISSN: 2001-3078
Titre abrégé: J Extracell Vesicles
Pays: United States
ID NLM: 101610479
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
20
07
2022
received:
20
07
2022
accepted:
20
07
2022
entrez:
31
8
2022
pubmed:
1
9
2022
medline:
3
9
2022
Statut:
ppublish
Résumé
EVs have emerged as an important component in tumour initiation, progression and metastasis. Although notable progresses have been made, the detection of EV cargoes remain significantly challenging for researchers to practically use; faster and more convenient methods are required to validate the EV cargoes, especially as biomarkers. Here we show, the possibility of examining embedded EVs as substrates to be used for detecting DNA amplification through ultrasensitive in situ hybridization (ISH). This methodology allows the visualization of DNA targets in a more direct manner, without time consuming optimization steps or particular expertise. Additionally, formalin-fixed paraffin-embedded (FFPE) blocks of EVs allows long-term preservation of samples, permitting future studies. We report here: (i) the successful isolation of EVs from liposarcoma tissues; (ii) the EV embedding in FFPE blocks (iii) the successful selective, specific ultrasensitive ISH examination of EVs derived from tissues, cell line, and sera; (iv) and the detection of MDM2 DNA amplification in EVs from liposarcoma tissues, cell lines and sera. Ultrasensitive ISH on EVs would enable cargo study while the application of ISH to serum EVs, could represent a possible novel methodology for diagnostic confirmation. Modification of probes may enable researchers to detect targets and specific DNA alterations directly in tumour EVs, thereby facilitating detection, diagnosis, and improved understanding of tumour biology relevant to many cancer types.
Identifiants
pubmed: 36043432
doi: 10.1002/jev2.12251
pmc: PMC9428764
doi:
Substances chimiques
DNA
9007-49-2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12251Subventions
Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States
Informations de copyright
© 2022 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles.
Références
Diagn Mol Pathol. 2003 Mar;12(1):1-13
pubmed: 12605030
Mol Cancer. 2022 Feb 18;21(1):56
pubmed: 35180868
J Extracell Vesicles. 2021 Feb;10(4):e12062
pubmed: 33643547
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9066-E9075
pubmed: 29073103
Malays J Pathol. 2019 Aug;41(2):149-160
pubmed: 31427550
J Mol Diagn. 2012 Jan;14(1):22-9
pubmed: 22166544
Carcinogenesis. 2020 Nov 13;41(11):1461-1470
pubmed: 33047121
iScience. 2020 Jan 24;23(1):100782
pubmed: 31958756
J Extracell Vesicles. 2018 Aug 07;7(1):1505403
pubmed: 30108686
Lab Invest. 2011 Mar;91(3):392-403
pubmed: 21060307
Analyst. 2021 Apr 7;146(7):2264-2276
pubmed: 33599630
J Extracell Vesicles. 2021 Jul;10(9):e12125
pubmed: 34295457
Nat Protoc. 2021 Mar;16(3):1548-1580
pubmed: 33495626
Anal Chem. 2021 Jun 22;93(24):8414-8422
pubmed: 34114453
Circ Res. 2017 May 12;120(10):1632-1648
pubmed: 28495994
Signal Transduct Target Ther. 2020 Aug 3;5(1):144
pubmed: 32747657
Nat Commun. 2021 May 5;12(1):2536
pubmed: 33953198
Stem Cells. 2014 Apr;32(4):983-97
pubmed: 24715691
J Extracell Vesicles. 2021 Jul;10(9):e12121
pubmed: 34295456
J Extracell Vesicles. 2019 Aug 27;8(1):1635420
pubmed: 31497264
Sci Transl Med. 2016 Aug 31;8(354):354re3
pubmed: 27582061
Cells. 2018 Aug 01;7(8):
pubmed: 30071693
Nanoscale. 2018 Jan 18;10(3):881-906
pubmed: 29265147
Ann Oncol. 2018 Dec 1;29(12):2379-2383
pubmed: 30339193
Biosens Bioelectron. 2016 Dec 15;86:202-210
pubmed: 27372573
Nat Rev Clin Oncol. 2018 Oct;15(10):617-638
pubmed: 29795272
Cancers (Basel). 2022 Mar 08;14(6):
pubmed: 35326514
Mol Cancer. 2019 Mar 11;18(1):39
pubmed: 30857545
Cancer Lett. 2020 Sep 1;487:27-33
pubmed: 32470489
Ann Surg Oncol. 2021 Dec;28(Suppl 3):832-834
pubmed: 34338924
Int J Biol Sci. 2019 Jan 6;15(1):1-11
pubmed: 30662342
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Med Oncol. 2020 Mar 14;37(4):28
pubmed: 32172294
Int J Clin Exp Pathol. 2013 Jun 15;6(7):1306-16
pubmed: 23826411
Front Cell Dev Biol. 2021 Feb 02;8:622048
pubmed: 33604335
Cell Res. 2014 Jun;24(6):766-9
pubmed: 24710597
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
J Biol Chem. 2014 Feb 14;289(7):3869-75
pubmed: 24398677
Oncotarget. 2017 Jan 3;8(1):1416-1428
pubmed: 27902458
Acta Histochem. 2021 Sep;123(6):151765
pubmed: 34364165
Biomaterials. 2015 Jun;54:116-25
pubmed: 25907045
Front Cell Dev Biol. 2021 Jan 21;8:622579
pubmed: 33575258
Analyst. 2020 May 7;145(9):3289-3296
pubmed: 32255115
Ann Oncol. 2017 Apr 1;28(4):741-747
pubmed: 28104621
Sci Rep. 2018 Oct 18;8(1):15438
pubmed: 30337610
BMC Clin Pathol. 2006 Jan 18;6:2
pubmed: 16420697
J Extracell Vesicles. 2017 Jul 26;6(1):1348885
pubmed: 28804598
Oncotarget. 2016 Aug 2;7(31):50086-50098
pubmed: 27418137
Cancer Biol Ther. 2017 Mar 4;18(3):158-165
pubmed: 28121262
J Hum Genet. 2017 Jan;62(1):67-74
pubmed: 27383658
Exp Cell Res. 2010 Jul 15;316(12):1977-84
pubmed: 20399774
Cell Death Dis. 2020 Jul 27;11(7):584
pubmed: 32719324
J Extracell Vesicles. 2022 Mar;11(3):e12191
pubmed: 35234354
Cancer Res. 2019 Oct 1;79(19):4911-4922
pubmed: 31387924
Ann Hematol. 2019 Mar;98(3):595-603
pubmed: 30673813
Acta Pharmacol Sin. 2018 Apr;39(4):499-500
pubmed: 29606702
Exp Mol Med. 2019 Mar 15;51(3):1-11
pubmed: 30872567
Pathol Oncol Res. 2021 Nov 08;27:1609971
pubmed: 35370480
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Dev Cell. 2019 May 6;49(3):347-360
pubmed: 31063754
Cancer Res. 2017 Jul 15;77(14):3846-3856
pubmed: 28588009
Chemistry. 2000 Apr 3;6(7):1107-11
pubmed: 10785794
Ann Surg Oncol. 2009 Mar;16(3):667-75
pubmed: 19101765
J Orthop Sci. 2017 Jul;22(4):601-612
pubmed: 28274512
J Clin Invest. 2016 Apr 1;126(4):1152-62
pubmed: 27035807
Int J Cancer. 2018 Feb 1;142(3):607-617
pubmed: 28975613
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S52-S63
pubmed: 30033809
Cells. 2020 Aug 25;9(9):
pubmed: 32854228
Biosens Bioelectron. 2019 Dec 15;146:111749
pubmed: 31600625
J Mol Cell Biol. 2013 Aug;5(4):227-38
pubmed: 23580760
Int J Cancer. 2019 Apr 1;144(7):1486-1495
pubmed: 30155891
Mol Biotechnol. 2001 Sep;19(1):29-44
pubmed: 11697219
Nat Methods. 2021 Sep;18(9):1013-1026
pubmed: 34446922
Sci Rep. 2020 Sep 25;10(1):15745
pubmed: 32978468
J Histochem Cytochem. 2001 May;49(5):603-12
pubmed: 11304798
Curr Cancer Drug Targets. 2005 Feb;5(1):27-41
pubmed: 15720187
Nat Methods. 2019 Dec;16(12):1269-1273
pubmed: 31712780
J Vis Exp. 2019 Feb 7;(144):
pubmed: 30799860
J Extracell Vesicles. 2020 Jun 30;9(1):1785746
pubmed: 32944174
Cancer Res. 2019 May 15;79(10):2462-2465
pubmed: 31043377